1. Market Research
  2. > Biopharmaceutical Market Trends
  3. > Biosimilar Industry

Biosimilar Industry Statistics

You might be interested in: Pharmaceutical, Therapy, Healthcare, Hospital, Vaccine, Biopharmaceutical, Bioprocessing, Biologic Medicine, Biomedical, Erythropoietin, Follow-On Biologic.

1-7 of about 100 reports for Biosimilar

Global Biosimilar Industry

  • January 2018
    9 pages
  • Biosimilar  

    Biotherapeutic  

  • World  

    Switzerland  

View report >

Biosimilar Market in the US - Forecast

  • January 2018
    7 pages
  • Pharmaceutical  

    Biosimilar  

    Hospital  

  • United States  

View report >

Biosimilar Statistics in the US and Europe

  • June 2017
    4 pages
  • Biosimilar  

    Monoclonal Anti...  

  • United States  

    Europe  

    North America  

View report >

Biosimilar Industry in China

  • December 2017
    5 pages
  • Biosimilar  

    Stomach Cancer  

  • China  

    Asia  

View report >

Biosimilar Industry in the UK - Forecast

  • March 2018
    7 pages
  • Biosimilar  

  • United Kingdom  

View report >

Biosimilar Industry in Australia and Australasia

  • September 2017
    11 pages
  • Biosimilar  

  • Australia  

    Oceania  

    European Union  

View report >

Biosimilar Industry in Canada

  • January 2018
    55 pages
  • Biosimilar  

    Therapy  

  • Canada  

    North America  

View report >
About 200 reports for Biosimilar

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 10995)

Biosimilars Market by Product, Manufacturing Type, Disease - Global Forecast to 2023

Biosimilars Market: Global Forecast until 2023

  • $ 5650
  • Industry report
  • April 2018
  • by MarketsandMarkets

The global biosimilars market projected to grow at a CAGR of 31.7% during the forecast period.The biosimilars market is expected to reach USD 23.63 billion by 2023 from USD 5.95 billion in 2018, at a CAGR ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on